BCM Technologies’ (BCMT) investment strategy revolves around the concept that maximum returns from early stage life science investing will result from impeccable diligence and a solid understanding of the underlying science. BCMT likes to invest early and create substantial value by leveraging the experience of the team to guide the company through the start-up process and avoid common mistakes. Success at such an early stage requires constant rationalization of investments and extreme discipline to focus on the likely winners.
“BCMT brings business acumen to company development: seasoned CEOs; venture capital; and management expertise to jump start opportunities for faculty.” –Dr. Paul Klotman, President and CEO of Baylor College of Medicine
BCMT is a true “early-stage investor” that provides seed capital to perform value creating proof-of-concept research and plays a major role in the structuring and development of the start-up company. The initial investment from BCMT is often made for the specific goal of validating the technology through highly focused research activities and initial investment frequently precedes recruitment of a management team. BCMT prefers to lead Seed and First rounds and will continue to co-invest in later rounds.
With proven success in identifying, protecting and commercializing innovative technologies from academic institutions, pharmaceutical companies, and other sources, we seek unique technologies with solid intellectual property positions.